WO2026030635 - PCV2E, PCV3C, AND PCV4 VACCINES
National phase entry is expected:
Publication Number
WO/2026/030635
Publication Date
05.02.2026
International Application No.
PCT/US2025/040186
International Filing Date
31.07.2025
Title **
[English]
PCV2E, PCV3C, AND PCV4 VACCINES
[French]
VACCINS CONTRE PCV2E, PCV3C ET PCV4
Applicants **
VST LLC DBA MEDGENE
Inventors
YOUNG, Alan John
Priority Data
63/678,659
02.08.2024
US
63/678,663
02.08.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2645 | |
| EPO | Filing, Examination, Granting | 15296 | |
| Japan | Filing, Examination, Granting | 2307 | |
| South Korea | Filing, Examination, Granting | 2496 | |
| USA | Filing, Examination, Granting | 5510 |
Total:
28,254
Contact Us
Abstract[English]
The present invention describes immunogenic compositions containing immunogenic polypeptides of Porcine circovirus 2e, 3c, or 4 (PCV2e, PCV3c, or PCV4), including immunogenic compositions containing antigens other than PCV2e, PCV3c, or PCV4 antigens, including antigens that may be used in immunization against pathogens that cause diarrheal diseases. Methods of eliciting an immune response with the immunogenic compositions as disclosed and methods of treating a PCV2e, PCV3c, or PCV4 infection are also described.[French]
La présente invention décrit des compositions immunogènes contenant des polypeptides immunogènes de circovirus porcin de type 2e, 3c, ou 4 (PCV2e, PCV3c, ou PCV4), y compris des compositions immunogènes contenant des antigènes autres que les antigènes PCV2e, PCV3c ou PCV4, notamment des antigènes qui peuvent être utilisés dans l'immunisation contre des pathogènes responsables de maladies diarrhéiques. L'invention concerne également des procédés visant à induire une réponse immunitaire au moyen de ces compositions immunogènes ainsi que des méthodes de traitement d'une infection par le PCV2e, le PCV3c ou le PCV4.